APOA1 and ovarian carcinoma: However, there are studies that induced tumors with previously treated cells, such as Mariho et al. (2018), who treated SKOV3 ovarian cancer cells with ApoA1 and CDDP, and later that day, deposited it in the CAM, continuing with the treatment to induce tumor formation [61].